BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12903803)

  • 1. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.
    Stanley MA
    Expert Rev Vaccines; 2003 Jun; 2(3):381-9. PubMed ID: 12903803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccines.
    Stanley MA
    Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
    Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
    Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a human papillomavirus vaccine.
    Rowen D; Lacey C
    Dermatol Clin; 1998 Oct; 16(4):835-8. PubMed ID: 9891690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards vaccines against human papillomavirus type-16 genital infections.
    Cason J; Khan SA; Best JM
    Vaccine; 1993; 11(6):603-11. PubMed ID: 8391738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.
    Cornelison TL
    Curr Opin Oncol; 2000 Sep; 12(5):466-73. PubMed ID: 10975555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
    Devaraj K; Gillison ML; Wu TC
    Crit Rev Oral Biol Med; 2003; 14(5):345-62. PubMed ID: 14530303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of vaccinology with special reference to papillomavirus vaccines.
    Hilleman MR
    J Clin Virol; 2000 Oct; 19(1-2):79-90. PubMed ID: 11091151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic and therapeutic vaccine therapy in papillomavirus infections].
    Vinatier D; Cosson M; Dufour P
    Gynecol Obstet Fertil; 2000 May; 28(5):370-84. PubMed ID: 10893881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomavirus vaccines.
    Duggan-Keen MF; Brown MD; Stacey SN; Stern PL
    Front Biosci; 1998 Dec; 3():D1192-208. PubMed ID: 9835649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer, human papillomavirus and vaccines.
    Khan SA
    Clin Oncol (R Coll Radiol); 1993; 5(6):386-90. PubMed ID: 8305362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
    Villa LL; Costa RL; Petta CA; Andrade RP; Ault KA; Giuliano AR; Wheeler CM; Koutsky LA; Malm C; Lehtinen M; Skjeldestad FE; Olsson SE; Steinwall M; Brown DR; Kurman RJ; Ronnett BM; Stoler MH; Ferenczy A; Harper DM; Tamms GM; Yu J; Lupinacci L; Railkar R; Taddeo FJ; Jansen KU; Esser MT; Sings HL; Saah AJ; Barr E
    Lancet Oncol; 2005 May; 6(5):271-8. PubMed ID: 15863374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccines for cervical cancer.
    Murakami M; Gurski KJ; Steller MA
    J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A vaccine to control cervix carcinoma will soon be available].
    Vetter C
    MMW Fortschr Med; 2006 Apr; 148(16):14. PubMed ID: 16688942
    [No Abstract]   [Full Text] [Related]  

  • 18. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus-like particle based vaccines: cervical cancer and beyond.
    Schiller JT; Lowy DR
    Expert Opin Biol Ther; 2001 Jul; 1(4):571-81. PubMed ID: 11727495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccine development.
    Fife KH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S8-10. PubMed ID: 9842094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.